AI Risk Models for Suicide and Relapse

Suicide risk models and relapse risk models should not be treated as the same tool.

One is built for same-day safety response. The other is built for early follow-up before treatment engagement slips further. When organizations use one workflow for both, staff response, documentation, and escalation can drift off track.

For behavioral health leaders, the issue is not only model accuracy. It is whether the alert leads to the right next step inside the EHR, with clear ownership, documented follow-up, and privacy controls that fit behavioral health and SUD care.

At a glance:

• Suicide models often use psychiatric history, prior self-harm, screening scores, medications, utilization shifts, and note language.
• Relapse models often use attendance patterns, MAT or MOUD gaps, toxicology, cravings, sleep, mood, and outreach activity.
• Suicide alerts usually need an interruptive workflow and a same-day clinical review.
• Relapse alerts usually fit task queues, worklists, and outreach workflows.
• Dual-risk cases need one rule set with suicide response first and relapse follow-up routed after safety review.
• Research cited in the source article notes suicide model discrimination near 0.85 AUC in live settings, while one relapse model cited reached 0.76 AUROC. Those numbers matter, but staff response design matters just as much.

AI Suicide vs. Relapse Risk Models: Key Differences at a Glance

Quick Comparison

The bottom line for treatment centers is simple: the model only matters if the platform turns the score into action. That means alert design, staffing rules, audit trails, and follow-up tracking carry as much weight as the model itself.

1. Opus Behavioral Health EHR

Opus Behavioral Health EHR is built for addiction treatment, SUD, and behavioral health organizations. It brings EHR data, telehealth activity, lab results, and AI-driven risk monitoring into one system.

For treatment centers that want to support both suicide risk and relapse risk workflows, that shared data layer matters. The main difference is not the platform. It is how each model reads the data and where each alert sends the next action.

Model inputs

The two models rely on different signals because they are trying to answer different clinical questions.

Suicide inputs include diagnoses, PHQ-9, GAD-7, and C-SSRS scores, prior attempts, overdose or detox history, medication history, and note language tied to ideation, hopelessness, or access to means.

Relapse inputs include missed visits, missed groups, MOUD or MAT gaps, early refill requests, abnormal urine drug screens, and shifts in messaging or telehealth use. Patient-reported cravings, mood, sleep, and coping confidence can make relapse risk scoring more precise. AI can also pull distress signals from notes, transcripts, and free-text reports.

Those differences shape what the model produces and how staff should respond.

Output design

Tiered risk levels work well here: low, medium, and high. Each alert should also show the main factors behind the score, such as a sharp PHQ-9 increase or several days of missed MAT dosing. That gives clinicians immediate context instead of forcing them to guess why the alert appeared.

In Opus, these outputs tend to work best when they sit inside the patient chart and task queue. Suicide risk alerts are better suited to hard-stop pop-ups or real-time push notifications because the risk may call for immediate review. Relapse risk alerts fit better as daily high-risk lists or in-chart flags, where care teams can act the same day without disrupting every encounter.

That split in workflow becomes easier to see when suicide and relapse models are viewed side by side.

Alert response

The response path should not be the same for both alert types. A high suicide risk flag should start a structured assessment workflow inside the encounter. That usually includes the C-SSRS, a safety plan template, and means-restriction prompts. It should also send an immediate notification to the clinical supervisor, on-call psychiatrist, or crisis team through secure messaging or direct call.

A high relapse risk flag calls for a different kind of action. It is usually a prompt for early outreach rather than crisis escalation. The alert can create tasks for the case manager or peer recovery coach, prompt the prescriber to review MAT dosing or other medication options, and auto-offer same-day telehealth appointments through Opus workflows.

The table below shows the difference in urgency and follow-up.

Clinical governance

Opus supports HIPAA and 42 CFR Part 2 controls through role-based access, MFA, and encryption. Audit logs can track score views and follow-up actions, which helps with quality control and internal review.

Behavioral health leaders should also review model performance on a routine basis. That includes sensitivity, specificity, and calibration, along with disparity checks across race, age, gender, ethnicity, insurance type, and primary substance.

A formal AI governance committee, often made up of clinical leaders, nursing, compliance officers, and IT or data science staff, should decide when thresholds need to change, when retraining is needed, and when a rollback makes sense.

These workflow decisions prepare the ground for the side-by-side comparison of suicide and relapse models below.

2. Suicide Risk Models in Behavioral Health Platforms

Suicide risk models in behavioral health platforms are supervised machine-learning tools trained on large, multi-system EHR datasets.

Their job is to flag elevated risk before a crisis occurs. In operational terms, this makes suicide risk modeling the most time-sensitive side of the comparison. These models are built to support same-day safety action, while relapse models are more often used for earlier outreach, follow-up, and retention planning.

Model inputs

Most suicide risk models use structured data that already exists in the EHR. Common inputs include demographics, diagnostic codes, psychiatric and medical comorbidities, prior suicide attempts or self-harm, hospitalizations, emergency visits, psychotropic medication history, and selected lab results.^[2][9]

Utilization patterns also matter. Sudden shifts in visit frequency or recent psychiatric admissions can point to instability in care, which may signal increased risk.^[11][12][5]

Many models perform better when they also use unstructured clinical notes. That is often where teams document context that does not fit neatly into coded fields.

Research using NLP to combine structured and unstructured EHR data found AUCs of up to 0.93 for first-time suicide attempts, compared with 0.901 for structured data alone.^[10][18] Veterans Health Administration research also found that NLP-derived models delivered 19% additional predictive accuracy and a 6-fold increase in risk concentration in the highest-risk tier compared with structured-data models.^[3]

Output design

Most platforms show model outputs as continuous scores that map to low, moderate, high, or very high risk. This format gives clinical teams a way to sort cases by urgency rather than treat risk as a simple yes-or-no issue.

A meta-analysis of live implementations reported a pooled AUC of about 0.85, which points to strong discrimination across health systems.^[13]

At the same time, suicide attempts are rare events. That creates a practical challenge: even a well-calibrated model can generate many false positives. For that reason, high-risk flags should be treated as prompts for clinical review, not proof that a suicide attempt is imminent.^[19][12]

Alert response

The way an alert appears can shape whether staff act on it. A passive flag buried in the chart may be easy to miss during a busy shift. An interruptive alert, while more disruptive, may drive a much stronger response.

Vanderbilt University Medical Center found that interruptive pop-up alerts led to suicide risk assessments in 42% of flagged encounters, compared with 4% when the same information appeared passively in the chart.^[17]

For behavioral health leaders, that finding has a direct workflow point: model accuracy matters, but alert design can have just as much effect on whether a risk signal changes care in the moment.

Clinical governance

Clinical governance is a core part of suicide risk model use. The Joint Commission's National Patient Safety Goal 15.01.01 requires U.S. behavioral health organizations to screen all patients age 12 and older who are being treated for behavioral health conditions with a validated tool, and to complete an evidence-based suicide risk assessment for patients who screen positive.^[14][15][16]

That means AI risk scores work best when they sit alongside required screening workflows, not when they try to replace them. In practice, the model can help teams focus attention, but standardized screening and assessment still anchor the care process.

Governance should also include equity review. Historical EHR data may underpredict risk in underrepresented groups, which can create blind spots if leaders rely on model output without checking for bias across populations.^[7][8]

These design and governance choices set suicide risk models apart from relapse models, which tend to depend more heavily on engagement signals and support intervention over a longer time horizon.

3. Relapse Risk Models in Addiction Treatment Platforms

Where suicide models focus on immediate safety, relapse models focus on early recovery support. These models look for signs of destabilization over several days or weeks. The goal is to spot warning signs before a lapse, so care teams can step in before the situation worsens.

Model inputs

Relapse risk models pull from several data sources. The main layer is structured EHR data. That often includes diagnosis codes for opioid use disorder, alcohol use disorder, co-occurring depression, and PTSD, along with prior detox or residential stays, medication-assisted treatment (MAT) orders, toxicology results, no-shows, and early discharges.^[20][21][22]

Clinical data is only part of the picture. Attendance and contact patterns often carry just as much weight. Lower group attendance, higher cancellation rates, and sudden increases in crisis contacts are all linked to higher relapse risk.^[20][25] Some platforms also use patient-reported data, such as daily or weekly smartphone check-ins on mood, cravings, sleep, and stress. In some cases, they also take in passive digital signals like screen time and mobility patterns.^{[20][6][4][24]}

Large-scale research found that craving and a poor recovery environment increased relapse risk, while longer lengths of stay and more therapy sessions were linked to lower risk.^[21]

Output design

Most platforms present relapse risk as a tiered score or a near-term probability. In one study, researchers used clinical lab data in an outpatient buprenorphine program to predict 7-day relapse risk at the individual level using only EHR-linked lab results. Clinicians found that output easy to interpret and use in care decisions.^[26]

The strongest outputs do more than post a number. They explain what is driving the score. Instead of a raw risk figure, platforms using methods like SHAP can show the factors behind each patient’s risk, such as missed groups, higher cravings, or fewer hours of sleep.^[22]

An XGBoost model with SHAP analysis reached an AUROC of 0.76, with drug use behaviors and personal characteristics ranking among the top risk features.^[22] Those drivers matter because they should shape the next outreach step, not just the alert itself.

Alert response

Alert workflows in relapse risk models are usually tiered by urgency. In practice, that often looks like this:

Strong programs do not stop at sending alerts. They track closed-loop follow-up rates, meaning the share of relapse alerts with documented follow-up inside a defined timeframe.

That helps leaders confirm the model is driving action rather than adding more notifications to the queue. Alert logic also needs to reflect staffing realities. After-hours or weekend flags may need to route to recovery coaches or crisis line instructions instead of sitting idle until the next business day.

Clinical governance

Governance for relapse models is more complex because of 42 CFR Part 2. Addiction treatment records carry stricter federal privacy rules than general health data.

That means organizations need written policies that spell out which data sources are used, how consent is handled, and how HIPAA and Part 2 requirements are maintained, especially when models draw from sensitive inputs like social media language or other behavioral patterns.^[20][6]

Equity review also matters. Organizations should review model performance across race, ethnicity, gender, age, and payer type to identify gaps in false-positive rates or differences in access to the services triggered by alerts.^[20][22][23] Governance should also define whether relapse alerts are advisory or mandatory, and what happens when follow-up is missed during performance reviews or payer audits.

Opus Behavioral Health EHR can route relapse alerts into documentation, lab review, and follow-up tasks. That helps keep alerts tied to documented action rather than notification volume alone.

4. Dual-Risk Workflows for Behavioral Health Care Teams

When the same patient triggers both models, care teams need one shared rule set, not two disconnected workflows. That matters in behavioral health settings, where the next step must be clear, fast, and tied to the type of risk in front of the clinician.

Model inputs

Both models may draw from the same encounter record, but they should not rely on the same logic. Suicide models put more weight on ideation, self-harm history, and screening scores. Relapse models focus more on substance use history, cravings, medication adherence, toxicology results, and gaps in engagement.

Keeping those input sets separate helps protect clinical judgment. If one risk signal bleeds into the other, the model can point teams in the wrong direction. In practice, that can create confusion at the point of care, since a suicide-risk response is not the same as a relapse-prevention response.

Output design

The alert design should make the acuity difference obvious. Suicide alerts should appear as interruptive, high-acuity events. Relapse alerts should appear as noninterruptive worklist flags.

Both are more useful when the platform shows why the alert fired. For example, an increased PHQ-9 suicidality score in the last 7 days gives the clinician something concrete to act on, rather than leaving staff to interpret a probability score with little context. That visual split helps teams move quickly when both alerts appear in the same chart.

Alert response

When both alerts fire, suicide risk takes priority. Safety stabilization comes first. Relapse follow-up should come after that and should be routed through a separate follow-up path.

The platform should also assign clear task ownership. Without that, two staff members may contact the same patient at the same time, or worse, each may assume the other already handled the case. The workflow needs one named owner for the next step, whether that is a clinician or an on-call provider. This is the practical divide: crisis response versus recovery retention.

Clinical governance

Dual-risk governance comes down to four core questions:

• Who owns the combined case?
• How is clinician override documented when model output conflicts with judgment?
• What escalation threshold applies when both alerts are active?
• How is missed follow-up tracked across both alert types?

Override documentation, audit logs, and defined escalation thresholds should apply to both model types. Performance review should also stay separate by workflow. Suicide-risk workflows should be measured through safety plan completion and crisis escalation rates. Relapse-risk workflows should be measured through attendance recovery, MAT adherence, and lapse-to-return time.

For executive teams and clinical leaders, the main operational signal is not alert volume. It is whether alert ownership is clear, documentation is complete, and follow-up happens when it should.

How Suicide and Relapse Models Differ in Practice

The clearest way to separate these two model types is to look at three things: what data goes in, what signal comes out, and what the care team is expected to do next. Both are built to spot deterioration before it turns into a crisis. But in day-to-day care, they follow different clinical logic.

The input gap matters in clinical practice. Suicide models are usually shaped by psychiatric vulnerability and crisis history. Recent suicidal ideation, psychiatric diagnoses, prior self-harm, recent inpatient or emergency use, and medication history can all change the score.

Relapse models, by contrast, tend to rely on signals tied to recovery engagement. Missed sessions, cravings, toxicology results, MAT adherence, and social stressors are often the variables that shift risk.

That pattern shows up in the research. A JAMA Network Open study found that a 30-day suicide attempt risk model used diagnoses, medications, visit utilization, and demographics from operational EHR data ^[27]. Relapse research shows that craving at discharge and at 3 months independently predicts relapse at both 3 months and 12 months ^[29].

The output also changes the workflow. Suicide models usually compress the timeline and force a direct question: does this patient need an immediate safety response right now? Relapse models often work across a longer monitoring window and produce graded tiers instead of a simple yes-or-no flag. That can guide how often staff should reach out, whether MAT support needs to change, or whether a higher level of care should be reviewed.

That said, relapse models are not always long-range tools. One opioid treatment study built a model to flag patients at high relapse risk in the following 7 days using clinical lab data ^[26]. For treatment centers, that is an important distinction. When overdose risk, disengagement, or medical instability are in play, relapse monitoring can move much closer to an urgent intervention workflow.

A platform like Opus Behavioral Health EHR can support both workflows in one place by bringing assessments, lab integration, telehealth engagement logs, and outcomes measurement into a shared chart view. This is especially useful for patients with co-occurring mental health and substance use disorders. In those cases, a clinician may need to see a rising suicide risk score and a missed MAT visit side by side before deciding on the next step.

"Reviewing weekly treatment results shows me what is really happening with my clients, even if they are not able to express it in session... We were able to work together to prevent a relapse, a crisis, and potential tragedy." - Andrea Horwitz, Clinical Director^[1]

Pros and Cons of Each Risk Model Approach

No risk model works well in every setting. The right choice depends on clinical use, staffing, follow-up capacity, and how alerts move through the organization. Those trade-offs shape how teams route alerts, assign outreach, and document next steps.

Suicide models can help surface patients who may not stand out during routine screening, but the signal is blunt. A meta-analysis found a pooled PPV of only 5.5% across clinical risk instruments ^[28]. That means most high-risk flags are false positives. In practice, those alerts should prompt clinical review, not automatic escalation.

Relapse models usually fit outpatient and longitudinal care settings more naturally because the response can be lighter and less disruptive. Still, model performance depends heavily on local data quality. Self-report bias, uneven documentation, and workflow differences between programs can weaken performance outside the original training setting.

The pressure point becomes clearer when both alerts appear in the same chart. A patient with co-occurring mental health and substance use needs one coordinated workflow, not two disconnected alert streams. Dual-risk workflows can help teams sort those cases faster, but only if leadership defines clear routing, clear ownership, and one escalation rule for cases where both alerts fire.

For executive teams, the issue is not just model accuracy. It is whether the organization can act on alerts in a consistent way without overloading staff.

Smaller programs may struggle with the staffing burden and governance controls that dual-risk workflows demand. Larger behavioral health systems often have more room to support role-based routing, care coordination, and separate response paths for suicide and relapse risk.

A platform like Opus Behavioral Health EHR can route alerts by severity and track response times so leaders can tune thresholds before alert fatigue builds.

Conclusion

The main point is straightforward: the model should fit the clinical job. Suicide and relapse AI models are not two versions of the same tool.

They rely on different data, work on different time horizons, and call for different actions from care teams. When organizations treat them as interchangeable, interventions can drift off course. A crisis-driven safety workflow may be used when a recovery-support response was the better fit, or the reverse.

For behavioral health leaders, the issue is not just model accuracy. It is whether the alert connects to a clear operational path. Strong implementations tie risk scores to defined thresholds, documented escalation steps, privacy controls, and in-workflow alerts. In practice, that makes workflow integration more important than model output alone.

Early visibility into mood, engagement, and clinical data can make both types of alerts easier to use. Platforms that bring together EHR, outcomes, labs, communication, and reporting may help teams respond without working across disconnected systems.

For organizations that want one platform, Opus Behavioral Health EHR combines those functions in a single system, so when a suicide alert fires, the team has a safety response ready, and when a relapse alert fires, the team has a recovery follow-up path in place.

FAQs

Why can’t one workflow handle both risks?

Suicide risk and relapse risk should not run through the same workflow. They reflect different clinical signals, unfold on different timelines, and call for different responses.

Relapse risk often comes from longitudinal patterns. Clinical teams may look at medication logs, attendance history, patient feedback, and other trend-based data to spot a change over time. Suicide risk is different. It often depends on immediate warning signs, abrupt shifts in behavior, and other signals that may call for urgent review.

In Opus Behavioral Health EHR, sending each risk score into its own documented workflow can help teams assign follow-up tasks, track completion, and connect each action to the patient record. That structure also helps reduce staff fatigue by avoiding a stream of generic alerts that offer little context or priority.

What should happen when both alerts fire?

When suicide and relapse risk alerts fire at the same time, the care team should treat suicide risk as the top priority because it presents an immediate patient safety threat.

Crisis-level indicators should trigger an immediate, high-priority response, including a clinical review and a safety plan. The relapse alert still matters, but it should guide follow-up care once the immediate emergency has been addressed.

How should teams measure whether alerts work?

Teams should use continuous evaluation to keep alerting useful and manageable. That means tracking a short set of performance metrics and reviewing staff feedback on a regular basis. Core measures often include response times, alerts per clinician per day, dwell time, and override rates.

Reporting helps leadership teams spot patterns that are easy to miss in day-to-day operations. It can show whether the actions taken after an alert are linked to fewer readmissions or emergency visits. That level of visibility can help organizations refine protocols, cut down false alarms, and keep alerts actionable for clinical teams.